Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase

Annals of the New York Academy of Sciences

Volumn 886, Issue , 1999, Pages 200-203

  Kim, Young Bae ^a   Yoshida, Minoru ^a   Horinouchi, Sueharu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; ENZYME INHIBITOR; FR 901228; HISTONE DEACETYLASE; OXAMFLATIN; RETINOBLASTOMA PROTEIN; TRICHOSTATIN A; UNCLASSIFIED DRUG;

CONFERENCE PAPER; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOSIS INHIBITION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033404304     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09416.x     Document Type: Conference Paper

References (11)

1. 1. Yoshida, M., S. Horinouchi & T. Beppu. 1995. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17: 423-430.
2. 2. Nakajima, H., Y.B. Kim, H. Terano et al. 1998. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp. Cell Res. 241: 126-133.
3. 3. Kim, Y.B., K.-H. Lee, K. Sugita et al. 1998. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase. Oncogene 18: 2461-2470.
4. 4. King, R.W., P.K. Jackson & M.W. Kirschner. 1994. Mitosis in transition. Cell 79: 563-571.
5. 5. Zerfass-Thome, K., A. Schulze, W. Zwerschke et al. 1997. p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17: 407-415.
6. 6. Magnaghi, J.L., R. Groisman, I. Naguibneva et al. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391: 601-605.
7. 7. Fujita, H., L.E. Laham, P.A. Janmey et al. 1995. Functions of [His321]gelsolin isolated from a flat revertant of ras-transformed cells. Eur. J. Biochem. 2295: 615-620.
8. 8. Akiyama, S.K. & K.M. Yamada. 1987. Fibronectin. Adv. Enzymol. Relat. Areas Mol. Biol. 59: 1-57.
9. 9. Sonoda, H., K. Nishida, T. Yoshioka et al. 1996. Oxamflatin: A novel compound which reverses malignant phenotype to normal one via induction of JunD. Oncogene 13: 143-149.
10. 10. Lepley, D.M. & J.C. Pelling. 1997. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog 19: 74-82.
11. 11. Caldas, C., S.A. Hahn, C.L. Da et al. 1994. Frequent somatic mutations and homozygous deletions of the p16(MTS1) gene in pancreatic adenocarcinoma. Nat. Genet. 8: 27-32.